News & Updates

Supplementation with vitamin D, otherwise called sunshine vitamin, and calcium may help women with breast cancer protect against bone loss associated with aromatase inhibitors (AIs), suggests a 5-year follow-up study from Brazil.

Gastrointestinal (GI) injury has developed in almost all patients receiving antiplatelet therapy despite being at low risk of bleeding, reveals a study, noting that overt bleeding is rare.

An already elevated serum uric acid level at baseline and achievement of high steady-state serum favipiravir concentrations during therapy contribute to an increased risk of developing treatment-induced hyperuricaemia, according to a study.

People who consume more olive oil in their diet have a lower risk of death from any cause or specific causes including cardiovascular disease (CVD), cancer, neurodegenerative disease, or respiratory disease compared with those who hardly or never consume olive oil, according to a large US study.

Individuals with risk factors such as pre-existing comorbid conditions, in addition to old age and being immunosuppressed, may still be at increased risk of developing severe COVID-19 illness even after completing their full vaccination, according to a study by the US CDC.

Long-term treatment with givosiran showed continued reduction in the composite annualized attack rate (AAR) of porphyria among patients with acute hepatic porphyria (AHP), according to the ENVISION* open-label extension (OLE) study presented at ASH 2021.

A shorter duration of anticoagulant therapy of 6 weeks is as effective in preventing recurrent thrombosis as the conventional 3-month treatment course without increasing the risk of bleeding in young patients aged below 21 years old with acute provoked venous thromboembolism, according to the Kids-DOTT* trial.